Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2026 · 10-Q
Revenue$5.55M$5.55M+20.6% vs Q3 2025 Net Income-$1.13M-$1.13MN/M vs Q3 2025 EPS, diluted—
Gross Profit$3,037,534+7.3% Operating Income-$1,130,477N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$442,158N/M Free Cash Flowderived-$460,223N/M Margins · derivedGross margin54.7%−6.8 pt vs Q3 2025
Operating margin-20.4%−0.7 pt vs Q3 2025
Net margin-20.3%−0.9 pt vs Q3 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end